Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.)
• Description:
  On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), inactivated poliovirus vaccine (IPV), and Haemophilus influenzae type b conjugate (tetanus toxoid [TT] conjugate) vaccine, DTaP-IPV/Hib (Pentacel, Sanofi Pasteur, Swiftwater, Pennsylvania), for use as a four-dose series in infants and children at ages 2, 4, 6, and 15-18 months. This report summarizes the indications for Pentacel and provides guidance from the Advisory Committee on Immunization Practices (ACIP) for its use.
• Subjects:
  Child, Preschool Diphtheria-Tetanus-acellular Pertussis Vaccines Diphtheria-Tetanus-Pertussis Vaccine Haemophilus Vaccines Humans Immunization Schedule Infant Licensure Poliovirus Vaccine, Inactivated Vaccines, Combined
• Source:
  MMWR. Morbidity and mortality weekly report. 2008; 57(39):1079-80.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  18830213
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  2 pdf pages
• Volume:
  57
• Issue:
  39
• Collection(s):
  Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:7cd18b25f2901fa6ef3874253b38691baf3a8c417d066ad7b7ef1449e9392407272f613ed73b354a8c31630ba1a9cbb5316aba817382191582ad1786ada2f88f
• Download URL:
  https://stacks.cdc.gov/view/cdc/7435/cdc_7435_DS1.pdf
• File Type:
  [PDF - 1.60 MB ]